URT logo

Urteste S.A. Stock Price

WSE:URT Community·zł56.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

URT Share Price Performance

zł40.00
-53.60 (-57.26%)
zł40.00
-53.60 (-57.26%)
Price zł40.00

URT Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
0 Rewards

Urteste S.A. Key Details

zł1.8m

Revenue

zł273.0k

Cost of Revenue

zł1.5m

Gross Profit

zł7.0m

Other Expenses

-zł5.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-3.88
84.83%
-303.72%
0%
View Full Analysis

About URT

Founded
2021
Employees
36
CEO
Grzegorz Stefanski
WebsiteView website
www.urteste.com

Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland.

Recent URT News & Updates

Recent updates

No updates